tiprankstipranks
Trending News
More News >
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market

Intellia Therapeutics (NTLA) Cash flow

Compare
4,593 Followers

Intellia Therapeutics Cash Flow

NTLA's free cash flow for Q3 2025 was $-76.93M. For the 2025 fiscal year, NTLA's free cash flow was decreased by $53.41M and operating cash flow was $-76.90M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -348.88M$ -394.09M$ -333.29M$ -225.03M$ -49.91M
Investing Cash Flow
$ 125.57M$ -31.35M$ 160.31M$ -550.78M$ -214.49M
Financing Cash Flow
$ 185.75M$ 130.32M$ 582.96M$ 736.69M$ 371.78M
End Cash Position
$ 202.79M$ 240.35M$ 535.46M$ 125.49M$ 164.61M
Free Cash Flow
$ -354.66M$ -408.07M$ -391.68M$ -237.79M$ -53.50M
Currency in USD

Intellia Therapeutics Cash Flow